Global Hematology Market: Snapshot

The strides in the global hematology market have been catalysed by multiple distinct factors. Advances in diagnostic technologies for hematologic malignancies and automation in devices have helped address current and emerging needs of patients in the hematology market. Over the past few years, new paradigms in medicine and health care have increasingly broadened the market potential. Hematology care encompassed by oncology, immunology, and molecular biology is opening new avenues in the hematology market. A case in point is through understanding of hematopoietic stem cells.

An understanding of success of specific treatments for haematological disorders has further quality of care in the hematology market.  Advances in cancer immunotherapy protocols play crucial role in shaping the contours of the market.

Get an Idea about the Offerings of Our Hematology Market Report from this Brochure

Global Hematology Market: Notable Developments

Recent spate of research has shed light on various types of risks for hematologic malignancies. Of these, familial relative risk (FRR) has been drawing the attention of researchers, which might pave way for new avenues in the hematology market. A recent study obtained 153,115 records of hematologic malignancies through Swedish Family-Cancer Database over nearly 70 years from 1958 to 2015. The researchers measured familial relative risks in the patients. The study highlighted some interesting results. FRR was higher in certain tumor types, in conditions when multiple relatives of individuals were affected, particularly when first-degree relatives were affected. Also the FRR was higher when relatives were diagnosed with myeloid malignancies at an earlier age.

The results have gained significance in the hematology market to devise appropriate diagnostic modules and identification of high-risk patients. This will boost awareness about the familial risks among patients and their families and clinicians.

Some of the prominent key players in the hematology market are:

  • Thermo Fisher Scientific Inc.
  • Fluidigm Corporation
  • F.Hoffmann-La Roche AG
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Abbott Laboratories

 Global Hematology Market: Growth Dynamics

Blood disorders are a substantial health and economic burden in worldwide populations. Growing prevalence of common blood disorders such as anaemia particularly among women, and haemophilia has been driving clinical advances in the hematology market. Prevalence of certain blood cancer in developed countries is also bolstered awareness for hematology testing. Increasing inclination of hematology care providers in automating testing technologies has opened lucrative avenues for device manufacturers, notably in emerging economies. Growing incidence of genetic blood disorders is also boosting the hematology market.

Over the years, interested stakeholders in the hematology market have benefitted from advances in understanding the biology of hematopoietic stem cells. An expanding cancer immunotherapy protocols have also expanded the potential of the market. Emerging area of induced pluripotent stem (iPS) cells will likely open new doors of opportunities in the not-so-distant future.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Hematology Market Report

The advent of instruments that help clinicians measure patient-reported outcomes (PRO) has taken the quality of care in the hematology market to a new trajectory. These outcomes are of vital prognostic value as they enable clinicians to incorporate patients’ perspective in the treatment process. PRO assessments are gathering steam in clinical trials as well as clinical practice.

Global Hematology Market: Regional Analysis

Among the various regions, North America has been showing vast revenue generating potential. Rising concern of blood-related disorders, notably in the U.S., and constant research for developing cutting-edge instruments have reinforces the prospects of the region in the hematology market. Meanwhile, Europe and Asia Pacific are potentially promising regional markets, with the latter showing considerable appetite for growth. Growing awareness of hematologic disorders and improving oncology care are aspects augmenting the prospects of the regional market. Advances made in transplant biology and immunology in Europe will help open numerous lucrative avenues in the region in the coming few years.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Hematology Market

Pre Book